Search research articles
Contact Us
Filters
Showing results (101-110 of 132) with videos related to
Page
of 14
Sort By:
Ugeskrift for Laeger
|
December 7, 2000
[How do patients evaluate the newly introduced system of substituting prescriptions?]
M L Andersen, K Laursen, M Schaumann, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 24, 2005
Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study
M Peyrot, R R Rubin, T Lauritzen, et al.
European Journal of Epidemiology
|
March 12, 2004
Markers of fetal growth and serum levels of insulin-like growth factor (IGF) I, -II and IGF binding protein 3 in adults
S P Johnsen, H T Sørensen, J L Thomsen, et al.
Clinical Chemistry
|
November 20, 1997
Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots
B S Dahler-Eriksen, J F Lassen, P H Petersen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 1, 2008
Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetes
T Parkner, T Laursen, E T Vestergaard, et al.
Diabetologia
|
January 7, 2006
Patient and provider perceptions of care for diabetes: results of the cross-national DAWN Study
M Peyrot, R R Rubin, T Lauritzen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 19, 2005
Pharmacokinetic profiles of biphasic insulin aspart 30/70 and 70/30 in patients with Type 1 diabetes: a randomized double-blinded crossover study
J-W Chen, T Lauritzen, J J Christiansen, et al.
Scandinavian Cardiovascular Journal : SCJ
|
September 13, 2000
Fetal growth and blood pressure in a Danish population aged 31-51 years
H T Sørensen, A M Thulstrup, B Nørgdård, et al.
Diabetes, Obesity & Metabolism
|
June 27, 2007
Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes
T Parkner, M K Møller, J W Chen, et al.
Diabetes, Obesity & Metabolism
|
April 27, 2010
Obesity does not influence the unique pharmacological properties of different biphasic insulin aspart preparations in patients with type 2 diabetes
T Parkner, S E Dyrskog, T Laursen, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 132) with videos related to
Sort By:
Page
of 14
Ugeskrift for Laeger
|
December 7, 2000
[How do patients evaluate the newly introduced system of substituting prescriptions?]
M L Andersen, K Laursen, M Schaumann, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 24, 2005
Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study
M Peyrot, R R Rubin, T Lauritzen, et al.
European Journal of Epidemiology
|
March 12, 2004
Markers of fetal growth and serum levels of insulin-like growth factor (IGF) I, -II and IGF binding protein 3 in adults
S P Johnsen, H T Sørensen, J L Thomsen, et al.
Clinical Chemistry
|
November 20, 1997
Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots
B S Dahler-Eriksen, J F Lassen, P H Petersen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 1, 2008
Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetes
T Parkner, T Laursen, E T Vestergaard, et al.
Diabetologia
|
January 7, 2006
Patient and provider perceptions of care for diabetes: results of the cross-national DAWN Study
M Peyrot, R R Rubin, T Lauritzen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 19, 2005
Pharmacokinetic profiles of biphasic insulin aspart 30/70 and 70/30 in patients with Type 1 diabetes: a randomized double-blinded crossover study
J-W Chen, T Lauritzen, J J Christiansen, et al.
Scandinavian Cardiovascular Journal : SCJ
|
September 13, 2000
Fetal growth and blood pressure in a Danish population aged 31-51 years
H T Sørensen, A M Thulstrup, B Nørgdård, et al.
Diabetes, Obesity & Metabolism
|
June 27, 2007
Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes
T Parkner, M K Møller, J W Chen, et al.
Diabetes, Obesity & Metabolism
|
April 27, 2010
Obesity does not influence the unique pharmacological properties of different biphasic insulin aspart preparations in patients with type 2 diabetes
T Parkner, S E Dyrskog, T Laursen, et al.
Page
of 14